2023 Generic Medicine Vaccines 
European Pharmaceutical Review
APRIL 3, 2023
It is the eighth vaccine recommended in the European Union (EU) for COVID-19. On 3 April 2023, the treatment was recommended by the CHMP for adults with neuromyelitis optica spectrum disorder (NMOSD) who are anti-aquaporin-4 (AQP4) antibody positive (Ab+).
STAT
OCTOBER 10, 2023
The state’s biotech scene exploded in the mid-2010s and early in the pandemic as exuberant investors disregarded the high failure rate in drug development and bet on buzzy technologies such as gene editing and messenger RNA vaccines. But the drumbeat of layoffs in 2022 has only grown louder this year.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Express Pharma
JUNE 12, 2024
In 2023, while the deal volume declined, the deal value grew (1), due to strategic megadeals in the pharma sector. Covid-19 promoted India to the centre stage of global vaccine export as the consumerisation of health providing an impetus for vaccines and prompt approvals. India’s pharmaceutical sector is on a growth trajectory.
Express Pharma
JUNE 21, 2024
In 2023, while the deal volume declined, the deal value grew1, due to strategic megadeals in the pharma sector. Covid-19 promoted India to the centre stage of global vaccines export as consumerisation of health providing an impetus for vaccines and prompt approvals. India’s pharmaceutical sector is on a growth trajectory.
Express Pharma
NOVEMBER 15, 2024
Integrating ESG considerations into core pharma operations India, known as the “Pharmacy of the World,” produces over 20 per cent of the global supply of generic medicines and plays a vital role in vaccine production, as per the Investindia.gov.in It meets the healthcare needs of over 1.4
Quality Matters
MAY 30, 2024
Drug shortages pose a significant, ongoing threat to our healthcare system and to the patients who rely on medicine for their wellbeing and survival. The USP Medicine Supply Map shows that 125 drug products were in shortage at the end of 2023, the highest number in a decade. drug shortages.
Quality Matters
APRIL 20, 2023
Launched in 2021 and composed of more than 250 million data points spanning 92% of generic medicines approved in the U.S., Perhaps most noticeably during the COVID-19 pandemic, this included approval or authorization of an unprecedented number of novel vaccines that help save lives.
Expert insights. Personalized for you.
98 
Let's personalize your content